Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33512749

Selinexor, a First in Class, Nuclear Export Inhibitor for the Treatment of Advanced Malignant Peripheral Nerve Sheath Tumor.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Oncologist
Publication date
2021 Apr
First author
Al-Ezzi E

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Al-Ezzi E
      type
      Author
    2. name
      Gounder M
      type
      Author
    3. name
      Watson G
      type
      Author
    4. name
      Mazzocca A
      type
      Author
    5. name
      D'Angelo SP
      type
      Author
    6. name
      Bravetti J
      type
      Author
    7. name
      Wang H
      type
      Author
    8. name
      Abdul Razak A
      type
      Author
    9. name
      Vincenzi B
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Al-Ezzi E
      type
      Author
    2. name
      Gounder M
      type
      Author
    3. name
      Watson G
      type
      Author
    4. name
      Mazzocca A
      type
      Author
    5. name
      D'Angelo SP
      type
      Author
    6. name
      Bravetti J
      type
      Author
    7. name
      Wang H
      type
      Author
    8. name
      Abdul Razak A
      type
      Author
    9. name
      Vincenzi B
      type
      Author
    bibliography ids
    1. nci-bib-57304f9c85c6074e3ee7023d
    book metadata
    content sha256
    e75b5dda5056b1bb3593f1c83a7f8301d0351774a988e9bd238798ac54122b62
    document type
    citation
    dois
    1. 10.1002/onco.13692
    electronic publication date
    display
    2021 Feb 17
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33512749
    immutable id
    pubmed:33512749@e75b5dda5056b1bb3593f1c83a7f8301d0351774a988e9bd238798ac54122b62
    journal
    abbreviation
    Oncologist
    issn electronic
    1549-490X
    issn print
    1083-7159
    issue
    4
    name
    The oncologist
    nlm unique id
    9607837
    pages
    e710-e714
    volume
    26
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33512749
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      19bbac3d600660f61585d5c910c165bd8a686d9573b4d5f340c3bd63c8acfe87
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Apr
      precision
      month
      year
      2021
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33512749/
      title
      Selinexor, a First in Class, Nuclear Export Inhibitor for the Treatment of Advanced Malignant Peripheral Nerve Sheath Tumor.

      Preserved source evidence · Not medical advice